ICGs, particularly the key members such as CTLA-4 and PD-1, are profoundly involved in immune tolerance and proliferation of glioma cells, and their blockage might inhibit the progression of gliomas (Ghouzlani et al., 2021). Here, CTLA4 is linked to central nervous system cancer.